← All trials
NCT01654601
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2012
- Primary completion
- Apr 1, 2013
- Completion date
- Aug 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- DongWha Pharmaceutical CompanyLead sponsor
- Catholic University of KoreaOverall official - principal investigator
- Catholic University of KoreaCollaborator
- Naju National HospitalCollaborator
- Wonkwang UniversityCollaborator
- Seoul National UniversityCollaborator
- Konkuk UniversityCollaborator
- Dongguk UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.